| __timestamp | Alnylam Pharmaceuticals, Inc. | Supernus Pharmaceuticals, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 50561000 | 116287000 |
| Thursday, January 1, 2015 | 41097000 | 136004000 |
| Friday, January 1, 2016 | 47159000 | 203017000 |
| Sunday, January 1, 2017 | 76545000 | 287023000 |
| Monday, January 1, 2018 | 73106000 | 393541000 |
| Tuesday, January 1, 2019 | 194688000 | 376095000 |
| Wednesday, January 1, 2020 | 414801000 | 467938000 |
| Friday, January 1, 2021 | 704143000 | 504714000 |
| Saturday, January 1, 2022 | 868601000 | 580017000 |
| Sunday, January 1, 2023 | 1517886000 | 523742000 |
| Monday, January 1, 2024 | 1924873000 |
Unleashing insights
In the competitive world of biotechnology, Alnylam Pharmaceuticals, Inc. and Supernus Pharmaceuticals, Inc. have been vying for dominance in gross profit generation over the past decade. From 2014 to 2023, Alnylam has shown a remarkable growth trajectory, culminating in a staggering 1,517% increase in gross profit by 2023. In contrast, Supernus, while consistent, has seen a more modest growth of around 350% during the same period.
Alnylam's breakthrough in 2023, with a gross profit of approximately 1.5 billion, marks a significant leap from its 2014 figures. Meanwhile, Supernus reached its peak in 2022, with a gross profit of nearly 580 million, before slightly declining in 2023. This data highlights the dynamic nature of the biotech industry, where innovation and strategic investments can lead to substantial financial gains.
Key Insights on Gross Profit: Johnson & Johnson vs Alnylam Pharmaceuticals, Inc.
Gross Profit Comparison: AbbVie Inc. and Supernus Pharmaceuticals, Inc. Trends
Who Generates Higher Gross Profit? GSK plc or Alnylam Pharmaceuticals, Inc.
Who Generates Higher Gross Profit? Alnylam Pharmaceuticals, Inc. or United Therapeutics Corporation
Key Insights on Gross Profit: Alnylam Pharmaceuticals, Inc. vs Exelixis, Inc.
Alnylam Pharmaceuticals, Inc. vs Pharming Group N.V.: A Gross Profit Performance Breakdown
Gross Profit Comparison: Alnylam Pharmaceuticals, Inc. and Lantheus Holdings, Inc. Trends
Gross Profit Trends Compared: Alnylam Pharmaceuticals, Inc. vs Amneal Pharmaceuticals, Inc.
Gross Profit Trends Compared: Alnylam Pharmaceuticals, Inc. vs BioCryst Pharmaceuticals, Inc.
Dr. Reddy's Laboratories Limited and Supernus Pharmaceuticals, Inc.: A Detailed Gross Profit Analysis
Gross Profit Comparison: Bausch Health Companies Inc. and Supernus Pharmaceuticals, Inc. Trends
Who Generates Higher Gross Profit? Supernus Pharmaceuticals, Inc. or Travere Therapeutics, Inc.